Skip to content
Clinical Trials for Alzheimer's Disease

Chicago, Illinois

Alzheimer's disease clinical trials in Chicago, IL

14 Alzheimer's disease studies are recruiting participants at sites in Chicago as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Chicago at a glance

  • 14 studies are recruiting at a site in Chicago.
  • By phase: Phase 2 (1), Phase 3 (6), No phase (3), Observational (4). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (9), university, hospital or other (5).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Chicago

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville
    Registry record
    NCT07177352 · updated
  2. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    • Phase 3
    • Ages 55 to 80
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville
    Registry record
    NCT07717411 · updated
  3. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Great Lakes Clinical Trials - Andersonville
    Registry record
    NCT07602582 · updated
  4. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Re:Cognition Health - Chicago
    Registry record
    NCT06976216 · updated
  5. CommunityRx-Dementia + Peer Navigation (CRxDpeer)

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Chicago
    Study site
    University of Chicago
    Registry record
    NCT07346183 · updated
  6. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Great Lakes Clinical Trials - Andersonville
    Registry record
    NCT06976203 · updated
  7. Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music

    • No phase
    • Ages 55 and older
    • All sexes
    Sponsor
    Northwestern University
    Study site
    Northwestern University Feinberg School of Medicine
    Registry record
    NCT07775625 · updated
  8. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study sites
    John H. Stroger, Jr. Hospital of Cook County · University of Chicago - Medical Center
    Registry record
    NCT06563895 · updated
  9. Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device

    • Observational
    • Ages 40 to 90
    • All sexes
    Sponsor
    Neurogen Biomarking LLC
    Study site
    Insigth Hospital and Medical Center Chicago
    Registry record
    NCT07701161 · updated
  10. Communication Bridge 3 Study

    • Phase 2
    • Ages 18 to 100
    • All sexes
    Sponsor
    University of Chicago
    Study site
    University of Chicago - American School Building
    Registry record
    NCT06191198 · updated
  11. Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

    • No phase
    • Ages 50 to 90
    • All sexes
    Sponsor
    Northwestern University
    Study site
    Northwestern University
    Registry record
    NCT04240561 · updated
  12. Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

    • Observational
    • Ages 60 to 90
    • All sexes
    Sponsor
    GAP Innovations, PBC
    Study site
    Flourish Research - Chicago
    Registry record
    NCT06584357 · updated
  13. Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes

    • Observational
    • Ages 18 to 65
    • All sexes
    Sponsor
    PepsiCo Global R&D
    Study site
    Advanced Personalized Ideation Center (API) and Gatorade Sports Science Institute (GSSI), PepsiCo Global R&D - Life Sciences
    Registry record
    NCT07005895 · updated
  14. Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Alzheimer's Disease and Related Disorders Association, Inc
    Study site
    Full List of Active Sites
    Registry record
    NCT06170268 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Chicago, IL on ClinicalTrials.gov.

Ask about studies near Chicago

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call